Your browser doesn't support javascript.
loading
Comparative cardioprotective effects of carvedilol versus atenolol in a rat model of cardiorenal syndrome type 4.
Mohamed, Rasha M S M; Elshazly, Shimaa M; Nafea, Ola E; Abd El Motteleb, Dalia M.
Afiliação
  • Mohamed RMSM; Clinical Pharmacology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Elshazly SM; Pharmacology and Toxicology Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
  • Nafea OE; Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Zagazig University, Zagazig, 44519, Egypt. olanafea@zu.edu.eg.
  • Abd El Motteleb DM; Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia. olanafea@zu.edu.eg.
Naunyn Schmiedebergs Arch Pharmacol ; 394(10): 2117-2128, 2021 10.
Article em En | MEDLINE | ID: mdl-34398250

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atenolol / Cardiotônicos / Cardiomegalia / Síndrome Cardiorrenal / Carvedilol Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atenolol / Cardiotônicos / Cardiomegalia / Síndrome Cardiorrenal / Carvedilol Idioma: En Ano de publicação: 2021 Tipo de documento: Article